Charles Schwab’s Cidara Therapeutics CDTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.41M | Buy |
+49,432
| New | +$2.41M | ﹤0.01% | 2612 |
|
|
2024
Q2 | – | Sell |
-1,341
| Closed | -$24.7K | – | 3635 |
|
|
2024
Q1 | $24.7K | Hold |
1,341
| – | – | ﹤0.01% | 3423 |
|
|
2023
Q4 | $21.3K | Hold |
1,341
| – | – | ﹤0.01% | 3475 |
|
|
2023
Q3 | $25.3K | Hold |
1,341
| – | – | ﹤0.01% | 3486 |
|
|
2023
Q2 | $30.3K | Hold |
1,341
| – | – | ﹤0.01% | 3505 |
|
|
2023
Q1 | $34.1K | Buy |
+1,341
| New | +$34.1K | ﹤0.01% | 3424 |
|
|
2021
Q3 | – | Sell |
-1,250
| Closed | -$51K | – | 3509 |
|
|
2021
Q2 | $51K | Sell |
1,250
-2,503
| -67% | -$102K | ﹤0.01% | 3364 |
|
|
2021
Q1 | $200K | Sell |
3,753
-843
| -18% | -$44.9K | ﹤0.01% | 3321 |
|
|
2020
Q4 | $184K | Hold |
4,596
| – | – | ﹤0.01% | 3266 |
|
|
2020
Q3 | $262K | Hold |
4,596
| – | – | ﹤0.01% | 3081 |
|
|
2020
Q2 | $340K | Buy |
+4,596
| New | +$340K | ﹤0.01% | 2984 |
|
|
2017
Q2 | – | Sell |
-858
| Closed | -$134K | – | 3107 |
|
|
2017
Q1 | $134K | Hold |
858
| – | – | ﹤0.01% | 2981 |
|
|
2016
Q4 | $179K | Hold |
858
| – | – | ﹤0.01% | 2982 |
|
|
2016
Q3 | $197K | Hold |
858
| – | – | ﹤0.01% | 2923 |
|
|
2016
Q2 | $177K | Buy |
+858
| New | +$177K | ﹤0.01% | 2977 |
|